FDA Approves Abbott's Launch of Freenome's Blood-Based CRC Screening Test

Freenome's SimpleScreen CRC, a blood-based colorectal cancer screening test, received FDA approval and will be commercialized in the U.S. by Abbott to help millions of Americans who are overdue for screening.